stock

Catalent Inc. (CTLT)

0

Share

Stay up to date

Catalent, Inc., an S&P 500® Company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 14,000 people, including over 2,400 scientists and technicians, at more than 40 facilities across four continents, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey.

Financial Statements

Key Info

  • Industry: Pharmaceutical Preparation Manufacturing
  • Sector: Manufacturing
  • CEO Name:

Key Statistics

  • Stock Price: $130.44
  • Dividend Yield: 0%
  • Market Capitalization: $22,197,207,771
  • Shares Outstanding: 170,341,553
  • Number of Employees: 13,900
  • Trailing 12-Month EPS: $2.96
  • Trailing 12-Month DPS: $0
  • Payout Ratio: 0.0%

Important Dates

  • Next Earnings Date:
  • Next Ex-Dividend Date:

Price Trends

  • Current Stock Price: $130.44
  • 52-week high: $132.69
  • 52-week low: $79.65
  • 200-day moving average: $110.94
  • 50-day moving average: $119.44

Performance

  • 1-Month Price Return: 8.8%
  • 3-Month Price Return: 24.3%
  • 6-Month Price Return: 14.6%
  • 1-Year Price Return: 48.7%
  • 2-Year Price Return: 147.1%
  • 5-Year Price Return: 419.8%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast